Mitsubishi UFJ Asset Management
MRNA icon

Mitsubishi UFJ Asset Management’s Moderna MRNA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5M Buy
450,036
+25,411
+6% +$1.31M 0.02% 475
2026
Q1 		$21.6M Buy
424,625
+34,597
+9% +$1.61M 0.01% 504
2025
Q4 		$12M Sell
390,028
-24,187
-6% -$657K 0.01% 582
2025
Q3 		$10.7M Sell
414,215
-1,805
-0.4% -$50.4K 0.01% 584
2025
Q2 		$11.5M Sell
416,020
-243,230
-37% -$6.41M 0.01% 560
2025
Q1 		$18.7M Buy
659,250
+147,267
+29% +$5.23M 0.02% 506
2024
Q4 		$21.6M Sell
511,983
-6,744
-1% -$322K 0.02% 482
2024
Q3 		$34.7M Buy
518,727
+40,786
+9% +$3.74M 0.04% 357
2024
Q2 		$56.8M Buy
477,941
+31,468
+7% +$3.98M 0.07% 226
2024
Q1 		$47.6M Buy
446,473
+59,732
+15% +$6.02M 0.07% 250
2023
Q4 		$42M Buy
386,741
+23,288
+6% +$1.96M 0.07% 223
2023
Q3 		$37.5M Buy
363,453
+30,619
+9% +$3.42M 0.08% 216
2023
Q2 		$40.4M Buy
332,834
+17,669
+6% +$2.36M 0.08% 193
2023
Q1 		$48.4M Buy
315,165
+22,862
+8% +$3.77M 0.12% 150
2022
Q4 		$52.3M Buy
292,303
+24,991
+9% +$4.09M 0.14% 133
2022
Q3 		$31.6M Buy
267,312
+18,056
+7% +$2.74M 0.1% 171
2022
Q2 		$35.6M Buy
249,256
+9,337
+4% +$1.33M 0.16% 135
2022
Q1 		$41.3M Buy
239,919
+29,116
+14% +$4.9M 0.16% 124
2021
Q4 		$49.5M Buy
210,803
+25,184
+14% +$7.36M 0.2% 105
2021
Q3 		$71.4M Buy
185,619
+108,960
+142% +$40.2M 0.35% 61
2021
Q2 		$18M Buy
76,659
+16,706
+28% +$2.99M 0.1% 219
2021
Q1 		$7.85M Buy
59,953
+5,925
+11% +$859K 0.05% 389
2020
Q4 		$5.64M Buy
54,028
+1,499
+3% +$152K 0.04% 410
2020
Q3 		$3.72M Buy
52,529
+7,982
+18% +$557K 0.03% 448
2020
Q2 		$2.86M Buy
+44,547
New +$2.44M 0.03% 451
2020
Q1 		– Sell
-23,600
Closed -$446K – 1013
2019
Q4 		$446K Buy
+23,600
New +$419K 0.01% 786

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Mitsubishi UFJ Asset Management's MRNA Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Moderna (MRNA) stake by 6% in Q2 2026, buying an estimated $1.31M and bringing the position to 450,036 shares worth $31.5M. The position accounts for 0.02% of the portfolio, ranked #475.

Mitsubishi UFJ Asset Management first reported a position in MRNA in Q4 2019 and has held it in 26 quarters since. The position peaked at $71.4M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 450,036 shares of Moderna worth $31.5M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 25,411 Moderna shares in Q2 2026, an estimated $1.31M.
  • Moderna made up 0.02% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #475 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Moderna in Q4 2019 and has held it in 26 quarters since.
  • Mitsubishi UFJ Asset Management's Moderna position peaked at $71.4M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.